Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Article CommentaryPediatric Neuroimaging

Early Neuroimaging Markers in β Propeller Protein-Associated Neurodegeneration

L. Chiapparini and G. Zorzi
American Journal of Neuroradiology December 2022, 43 (12) 1815-1816; DOI: https://doi.org/10.3174/ajnr.A7723
L. Chiapparini
aNeuroradiology Unit Fondazione Institute for Hospitalization and Healthcare Policlinico San Matteo Pavia, ItalyNeuroradiology Unit Fondazione Institute for Hospitalization and Healthcare Istituto Neurologico Carlo Besta Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L. Chiapparini
G. Zorzi
bDepartment of Paediatric Neuroscience Fondazione Institute for Hospitalization and Healthcare Istituto Neurologico Carlo Besta Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Zorzi
  • Article
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Neurodegeneration with brain iron accumulation (NBIA) encompasses a heterogeneous group of rare diseases characterized by abnormal progressive iron accumulation in the basal ganglia (BG), movement disorders, and cognitive disability.1 β propeller protein-associated neurodegeneration (BPAN) is, to date, the most common NBIA disorder.2 It is caused by mutations in an X-linked gene, WDR45, which has an important role in autophagy.3⇓-5 The disease is more common in females and typically presents with global developmental delay, speech impairment, abnormal gate, sleep disturbances, and epilepsy in childhood followed by severe dystonia, parkinsonism, and progressive dementia in young adulthood, though the phenotypic spectrum is broader and includes Rett syndrome, developmental and epileptic encephalopathy, and intellectual disability.6⇓-8 The distinctive BPAN neuroradiologic findings are well-known in adolescence and adulthood and include the following: T2, T2*, and SWI hypointensity in the substantia nigra (SN) and GP; the “halo sign” on T1WI (ie, a symmetric hyperintense signal surrounding a thin, dark, central band in the SN and cerebral peduncles), which is pathognomonic for BPAN; a normal or thinned corpus callosum; and mild-to-moderate global cerebellar and cerebral atrophy.5,6,9,10 Findings of neuroimaging performed during early childhood are nearly all normal. In some cases, delayed myelination, nonspecific cerebellar and cerebral atrophy, and a thin corpus callosum have been described.2,11 Because the clinical features are not specific and imaging may not demonstrate the classic findings at a young age, the diagnosis is often made with gene panel or exome sequencing, which reveals a mutation in WDR45.7

The article by Papandreou et al,12 published in the current issue of the American Journal of Neuroradiology, represents an important retrospective cohort study of 15 pediatric patients with a confirmed pathogenetic WDR45 variant, focusing on early MR imaging features. The authors took into account a vast amount of neuroimaging findings and reported that early neuroradiologic features, in most cases, included dentate nuclei hyperintensity, GP and SN swelling and hyperintensity, as well as a thin corpus callosum and cerebral and cerebellar atrophy of various degrees. They also observed optic nerve thinning and an unusually small midbrain. Iron deposition was uncommon in patients younger than 4 years of age and was never present in children younger than 3 years of age but was evident in almost all patients scanned at 5 years of age or older.

A minor criticism of the present work12 was that the assessment of cerebral volume reduction, detected in most of the cases, was subjective and is actually unreliable due to lack of age-matched controls. Indeed, in children, subjective assessment of brain atrophy can be difficult because of craniocerebral disproportion. Furthermore, the authors report midbrain atrophy in all cases, whereas no obvious midbrain atrophy is observed in Fig 1 and, in general, in any of the other cases reported.13⇓⇓-16 Another critical issue concerns the assessment of optic nerve atrophy in axial sections, which we do not consider correct because in general, errors occur when measuring optic nerve diameter on axial images.

If one focuses on the GP and SN and on the iron-sensitive sequences (T2WI, T2*WI, and SWI), the most relevant evidence is that iron deposition is not present early in the course of the disease but accumulates with time. In particular, there is some sort of evolution of signal abnormalities in these structures from early childhood to early adulthood that could be considered highly specific for BPAN and that is represented by an early, enlarged GP and SN appearance, with slight T2 hyperintenisty and subsequent progressive iron accumulation. SWI sequences can detect very early iron deposition. Iron accumulates in the SN, emerging as the most affected nucleus and, to a lesser extent, in the GP. On T2WI or SWI, the SN results are usually more hypointense compared with the GP, a feature that may help distinguish BPAN from other forms of NBIA.9 Sometimes, on the T1WI the halo sign is evident in the SN.2,5 This is a late sign, and its absence in the article by Papandreou et al12 could be related to the young age of their patients (0–18 years of life).

Most interesting, it is not entirely clear why GP and SN enlargement and T2 hyperintensity predominate early. In four of our cases,15 we interpreted the swelling as a very early inflammation caused by dysfunction in the autophagy-lysosome complex. The authors12 also noted that similar neuroimaging findings have been reported in cases with biallelic WIPI2 mutations,17 which, similar to WDR45 (also known as WIP14), belong to the family of WD-repeat proteins, which have an essential role in the early stages of autophagy. We agree that it would be interesting to ascertain whether a similar neuroimaging pattern is present in other congenital autophagy disorders. It is certain, however, that neuroinflammation evolves rapidly in neurodegeneration and progressive iron deposition,18,19 highlighting how the first abnormality is due to cellular damage, while the accumulation of iron is probably only a late epiphenomenon of the degenerative process.20,21

Concerning other characteristic imaging signs, in all the cases reported by Papandreou et al12 and, in general in most of the cases reported in the literature,13⇓⇓-16 transient or persistently observed T2-hyperintense signal in the dentate nuclei is a typical finding that helps suggest the diagnosis. This is a finding not seen in other NBIA disorders and, from a pathophysiologic point of view, also probably related to chronic inflammatory changes.12 Delayed myelination is a transient, frequent finding that normalizes during the follow-up MR imaging;11,14 thin corpus callosum and cerebellar atrophy (present in other NBIA disorders) are prominent features frequently seen in early childhood11 but are nonspecific signs.

We believe one of the major merits of the present study is stressing the important role of early MR imaging findings to reach an accurate and early BPAN diagnosis for the best multidisciplinary management of these patients. Even though normal brain MR imaging findings do not exclude BPAN in a young child, early neuroimaging markers highlighted by Papandreou et al,12 such as GP and SN swelling, dentate nuclei T2 hyperintensity, corpus callosum thinning, and cerebral and cerebellar atrophy in the appropriate clinical context, may strongly suggest the diagnosis. In agreement with the authors, we believe that it is important to not discard a variant of WDR45 in the absence of iron accumulation in the basal ganglia in the early stages of the disease.

References

  1. 1.↵
    1. Hogarth P
    . Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord 2015;8:1–13 doi:10.14802/jmd.14034 pmid:25614780
    CrossRefPubMed
  2. 2.↵
    1. Wilson JL,
    2. Gregory A,
    3. Kurian MA, et al
    ; BPAN Guideline Contributing Author Group. Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration. Dev Med Child Neurol;2021;63:1402–09 doi:10.1111/dmcn.14980 pmid:34347296
    CrossRefPubMed
  3. 3.↵
    1. Saitsu H,
    2. Nishimura T,
    3. Muramatsu K, et al
    . De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet 2013;45:445–49, 449e1 doi:10.1038/ng.2562 pmid:23435086
    CrossRefPubMed
  4. 4.↵
    1. Hong Huan Hor C,
    2. Luen Tang B
    . Beta-propeller protein-associated neurodegeneration (BPAN) as a genetically simple model of multifaceted neuropathology resulting from defects in autophagy. Rev Neurosci 2019;30:261–77 doi:10.1515/revneuro-2018-0045 pmid:30204590
    CrossRefPubMed
  5. 5.↵
    1. Hayflick SJ,
    2. Kruer MC,
    3. Gregory A, et al
    . Beta-propeller protein-associated neurodegenration: a new X-linked dominant disorder with brain iron accumulation. Brain 2013;136:1708–17 doi:10.1093/brain/awt095 pmid:23687123
    CrossRefPubMed
  6. 6.↵
    1. Adang LA,
    2. Pizzino A,
    3. Malhotra A, et al
    . Phenotypic and imaging spectrum associated with WDR45. Pediatr Neurol 2020;109:56–62 doi:10.1016/j.pediatrneurol.2020.03.005 pmid:32387008
    CrossRefPubMed
  7. 7.↵
    1. Chen H,
    2. Qian Y,
    3. Yu S, et al
    . Early onset developmental delay and epilepsy in pediatric patients with WDR45 variants. Eur J Med Genet 2019;62:149–60 doi:10.1016/j.ejmg.2018.07.002 pmid:29981852
    CrossRefPubMed
  8. 8.↵
    1. Kano K,
    2. Yamanaka G,
    3. Muramatsu K, et al
    . Beta-propeller protein-associated neurodegeneration presenting Rett-like features: a case report and literature review. Am J Med Genet A 2021;185:579–83 doi:10.1002/ajmg.a.61993 pmid:33251766
    CrossRefPubMed
  9. 9.↵
    1. Kruer MC,
    2. Boddaert N,
    3. Schneider SA, et al
    . Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol 2012;33:407–14 doi:10.3174/ajnr.A2677 pmid:21920862
    Abstract/FREE Full Text
  10. 10.↵
    1. Ichinose Y,
    2. Miwa M,
    3. Onohara A, et al
    . Characteristic MRI findings in beta-propeller protein-associated neurodegeneration (BPAN). Neurol Clin Pract 2014;4:175–77 doi:10.1212/01.CPJ.0000437694.17888.9b pmid:24790802
    Abstract/FREE Full Text
  11. 11.↵
    1. Rathore GS,
    2. Schaaf CP,
    3. Stocco AJ
    . Novel mutation of the WDR45 gene causing beta-propeller protein-associated neurodegeneration. Mov Disord 2014;29:574–75 doi:10.1002/mds.25868 pmid:24610255
    CrossRefPubMed
  12. 12.↵
    1. Papandreou A,
    2. Soo A,
    3. Spaull R, et al
    . Expanding the spectrum of early neuroradiological findings in β propeller protein-associated neurodegeneration. AJNR Am J Neuroradiol 2022;43:1810–14 doi:10.3174/ajnr.A7693 pmid:36328404
    Abstract/FREE Full Text
  13. 13.↵
    1. Chard M,
    2. Appendino JP,
    3. Bello-Espinosa LE, et al
    . Single-center experience with beta-propeller protein-associated neurodegeneration (BPAN): expanding the phenotypic spectrum. Mol Genet Metab Rep 2019;20:100483 doi:10.1016/j.ymgmr.2019.100483 pmid:31293896
    CrossRefPubMed
  14. 14.↵
    1. Kimura Y,
    2. Sato N,
    3. Ishiyama A, et al
    . Serial MRI alterations of pediatric patients with beta-propeller protein associated neurodegeneration (BPAN). J Neuroradiol 2021;48:88–93 doi:10.1016/j.neurad.2020.04.002 pmid:32335071
    CrossRefPubMed
  15. 15.↵
    1. Russo C,
    2. Ardissone A,
    3. Freri E, et al
    . Substantia nigra swelling and dentate nucleus T2 hyperintensity may be early magnetic resonance imaging signs of β-propeller protein-associated neurodegeneration. Mov Disord Clin Pract 2019;6:51–56 doi:10.1002/mdc3.12693 pmid:30746416
    CrossRefPubMed
  16. 16.↵
    1. Christoforou S,
    2. Christodoulou K,
    3. Anastasiadou V, et al
    . Early-onset presentation of a new subtype of β-propeller protein-associated neurodegeneration (BPAN) caused by a de novo WDR45 deletion in a 6-year-old female patient. Eur J Med Genet 2020;63:103765 doi:10.1016/j.ejmg.2019.103765 pmid:31536831
    CrossRefPubMed
  17. 17.↵
    1. Maroofian R,
    2. Gubas A,
    3. Kaiyrzhanov R, et al
    . Homozygous missense WIPI2 variants cause a congenital disorder of autophagy with neurodevelopmental impairments of variable clinical severity and disease course. Brain Commun 2021;3:fcab183 doi:10.1093/braincomms/fcab183 pmid:34557665
    CrossRefPubMed
  18. 18.↵
    1. Liu Z,
    2. Shen H,
    3. Lian T, et al
    . Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance. Sci Rep 2017;7:1–7 doi:10.1038/s41598-016-0028-x
    CrossRefPubMed
  19. 19.↵
    1. Thomsen MS,
    2. Andersen MV,
    3. Christoffersen PR, et al
    . Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons. Neurobiol Dis 2015;81:108–18 doi:10.1016/j.nbd.2015.03.013 pmid:25801802
    CrossRefPubMed
  20. 20.↵
    1. Bodea L,
    2. Wang Y,
    3. Linnartz-Gerlach B, et al
    . Neurodegeneration by activation of the microglial complement: phagosome pathway. J Neurosci 2014;34:8546–56 doi:10.1523/JNEUROSCI.5002-13.2014 pmid:24948809
    Abstract/FREE Full Text
  21. 21.↵
    1. Ward RJ,
    2. Zucca FA,
    3. Duyn JH, et al
    . The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 2014;13:1045–60 doi:10.1016/S1474-4422(14)70117-6 pmid:25231526
    CrossRefPubMed
  • © 2022 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 43 (12)
American Journal of Neuroradiology
Vol. 43, Issue 12
1 Dec 2022
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Early Neuroimaging Markers in β Propeller Protein-Associated Neurodegeneration
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
L. Chiapparini, G. Zorzi
Early Neuroimaging Markers in β Propeller Protein-Associated Neurodegeneration
American Journal of Neuroradiology Dec 2022, 43 (12) 1815-1816; DOI: 10.3174/ajnr.A7723

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Neuroimaging in β Propeller Neurodegeneration
L. Chiapparini, G. Zorzi
American Journal of Neuroradiology Dec 2022, 43 (12) 1815-1816; DOI: 10.3174/ajnr.A7723
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • References
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Neuroimaging Delineation and Progression of SLSMD
  • fetal brain development of 10 weeks gestation
  • CHARGE fetal MRI clival cleft
Show more Pediatric Neuroimaging

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire